The Latest Cardiac and Vascular News
Fourth quarter 2021 revenue of $23.0 million contributed to record full year revenue of $81.6 million, 46% growth over the prior year Established over 75 new customer accounts, expanding and diversifying revenue base Substantial cash and investments of $657.7 million at year-end Maintaining 2022 full year revenue guidance of $105-110 […]
TOLEDO, Ohio & DIEST, Belgium–(BUSINESS WIRE)–NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its nearing acquisition of Medanex Clinic, a Belgium-based European preclinical research organization. Founded in 2010, Medanex focuses on providing exceptional preclinical services to the medical device industry in Europe and across the globe. […]
The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]
LOS ANGELES, March 29, 2022 /PRNewswire/ — Australian medical technology company, Artrya Limited, creator of the AI-based solution, Artrya Salix, that supports physicians in the diagnosis of coronary artery disease, today announces the formation of the Company’s American subsidiary, Artrya USA, Inc. (Artrya US) with its headquarters in Los Angeles, California. Ted Schwab and Jory Tremblay have been […]
DALLAS, March 29, 2022 /PRNewswire/ — Dynamic Infusion Therapy, LLC (“DIT”), a market leading provider of outsourced vascular access services, has announced the acquisition of Vascular Access Consultants based in Austin, Texas. Vascular Access Consultants has been providing expert services to healthcare facilities in Austin and the surrounding areas for the past 26 years under […]
– Proceeds to fund ACCESS 2 – a randomized clinical trial evaluating Sirogen™ for improving hemodialysis AV Fistula outcomes in high-risk patients – CRESSKILL, N.J., March 29, 2022 /PRNewswire/ — Vascular Therapies, Inc. a clinical-stage biopharma company focused on improving vascular access outcomes in patients with kidney disease, today announced the closing […]
— Advancing late-stage clinical and preclinical programs of the Human Acellular Vessel™ (HAV™) and other engineered tissues across several indications – — Multiple publications and scientific meeting presentations highlighting clinical and preclinical HAV results – — Conference call and live webcast at 8:00 am ET today – DURHAM, N.C., March […]
− NorthStar positioned for continued strong growth and setting leadership standards for domestic, environmentally sustainable radioisotope production across its portfolio to meet needs of health systems, radiopharmacies and patients – − NorthStar continues as the only U.S. commercial producer of diagnostic imaging radioisotopes non-uranium molybdenum-99 (Mo-99)/technetium-99m (Tc-99m), for more than […]
New 40,000 sqft facility offers additional advanced manufacturing capabilities as providers seek to improve medical outcomes using Access Vascular’s catheters BILLERICA, Mass., March 28, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced the opening of its new, 40,000 […]
Mr. Driscoll has over 25 years of biotech executive experience and most recently served as the CFO of Flexion Therapeutics through its sale to Pacira BioSciences for up to $1 billion PHILADELPHIA–(BUSINESS WIRE)–Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of […]
